These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 14261418)

  • 1. THE EFFECTS OF A NEW ORAL CONTRACEPTIVE ON GONADOTROPIN EXCRETION.
    STEVENS VC; VORYS N; BESCH PK; BARRY RD
    Metabolism; 1965 Mar; 14():SUPPL:327-38. PubMed ID: 14261418
    [No Abstract]   [Full Text] [Related]  

  • 2. SOME SYSTEMIC EFFECTS OF A PROGESTATIONAL AGENT (ETHYNODIOL DIACETATE AND MESTRANOL).
    BESCH PK; VORYS N; ULLERY JC; STEVENS V; BARRY RD
    Metabolism; 1965 Mar; 14():SUPPL:387-97. PubMed ID: 14261423
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative studies of the ethynyl estrogens used in oral contraceptives. III. Effect on plasma gonadotropins.
    Goldzieher JW; de la Peña A; Chenault CB; Cervantes A
    Am J Obstet Gynecol; 1975 Jul; 122(5):625-36. PubMed ID: 1146928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors affecting pituitary gonadotropin function in users of oral contraceptive steroids.
    Scott JA; Brenner PF; Kletzky OA; Mishell DR
    Am J Obstet Gynecol; 1978 Apr; 130(7):817-21. PubMed ID: 345817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The ovarian response to gonadotrophins after administration of an oral contraceptive.
    Pujol-Amat P; Urgell-Roca JM; Mároquez-Ramirez M
    J Obstet Gynaecol Br Commonw; 1971 Mar; 78(3):261-5. PubMed ID: 5558842
    [No Abstract]   [Full Text] [Related]  

  • 6. URINARY EXCRETION OF FOLLICLE-STIMULATING AND LUTEINIZING HORMONES.
    BECKER KL; ALBERT A
    J Clin Endocrinol Metab; 1965 Jul; 25():962-74. PubMed ID: 14319379
    [No Abstract]   [Full Text] [Related]  

  • 7. Experience with ethynodiol diacetate and mestranol as an oral contraceptive.
    Gidwani GP; Purandare BN
    J Obstet Gynaecol India; 1968 Apr; 18(2):287-93. PubMed ID: 12331821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma levels of adrenocorticotropin and cortisol in women receiving oral contraceptive steroid treatment.
    Carr BR; Parker CR; Madden JD; MacDonald PC; Porter JC
    J Clin Endocrinol Metab; 1979 Sep; 49(3):346-9. PubMed ID: 224073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of an oral contraceptive on urinary gonadotrophin in women at mid-cycle.
    Brown PS; Wells M; Warnock DG
    J Reprod Fertil; 1966 Jun; 11(3):481-3. PubMed ID: 5940546
    [No Abstract]   [Full Text] [Related]  

  • 10. [Daily fluctuation of the follicle-stimulating (FSH) and luteinizing (LH) hormone in the human plasma].
    Leyendecker G; Saxena BB
    Klin Wochenschr; 1970 Feb; 48(4):236-8. PubMed ID: 5523315
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of contraceptive steroids on hypothalamic-pituitary function.
    Mishell DR; Kletzky OA; Brenner PF; Roy S; Nicoloff J
    Am J Obstet Gynecol; 1977 May; 128(1):60-74. PubMed ID: 403765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of ovarian biopsies from women cyclically treated with the combination ethynodiol diacetate+mestranol alone and together with human menopausal gonadotrophin (Pergonal)+HCG.
    Pujol-Amat P; Urgell-Roca JM; Esteban-Altirriba J; Márquez-Ramirez M
    Gynaecologia; 1969; 167(4):237-49. PubMed ID: 5767877
    [No Abstract]   [Full Text] [Related]  

  • 13. COMPARISON OF THE CLINICAL AND STEROID METABOLIC EFFECT OF HUMAN PITUITARY- AND URINARY GONADOTROPHINS IN AMENORRHOEIC WOMEN.
    DICZFALUSY E; JOHANNISSON E; TILLINGER KG; BETTENDORF G
    Acta Endocrinol (Copenh); 1964; 45():SUPPL90:35-56. PubMed ID: 14111332
    [No Abstract]   [Full Text] [Related]  

  • 14. EXCRETION OF GONADOTROPINS AND 5-HYDROXYINDOLEACETIC ACID DURING NORMAL AND GESTAGEN-TREATED CYCLES.
    FUCHS AR; FUCHS F; JOHNSEN SG
    Int J Fertil; 1964; 9():139-45. PubMed ID: 14106247
    [No Abstract]   [Full Text] [Related]  

  • 15. A COMPARATIVE STUDY OF LOW DOSAGE ORAL CONTRACEPTIVES.
    SATTERTHWAITE AP
    Appl Ther; 1964 May; 6():410-8. PubMed ID: 14144491
    [No Abstract]   [Full Text] [Related]  

  • 16. PATIENT ACCEPTANCE OF ORAL CONTRACEPTION.
    ANDREWS WC; ANDREWS MC
    Metabolism; 1965 Mar; 14():SUPPL:446-50. PubMed ID: 14261431
    [No Abstract]   [Full Text] [Related]  

  • 17. THE LONG-TERM USE OF OVULEN FOR CONTRACEPTION.
    HOLMSTROM EG
    Metabolism; 1965 Mar; 14():SUPPL:444-5. PubMed ID: 14261430
    [No Abstract]   [Full Text] [Related]  

  • 18. Pituitary gonadotropins during long-term Enovid therapy.
    Ryan GM; Goss DA; Reid DE
    Am J Obstet Gynecol; 1966 Feb; 94(4):515-7. PubMed ID: 5903672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HORMONAL OVULATION INHIBITION WITH OVULEN].
    HEINEN G
    Med Welt; 1964 Dec; 49():2631-4. PubMed ID: 14339443
    [No Abstract]   [Full Text] [Related]  

  • 20. Endocrinological studies in two patients with post contraceptive cyclic dysfunction.
    Adamopoulos DA; Loraine JA; Ginsburg J; Loudon NB
    Scott Med J; 1972 Aug; 17(8):270-4. PubMed ID: 4642685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.